Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H6N2O |
| Molecular Weight | 134.1353 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1NC2=C(N1)C=CC=C2
InChI
InChIKey=SILNNFMWIMZVEQ-UHFFFAOYSA-N
InChI=1S/C7H6N2O/c10-7-8-5-3-1-2-4-6(5)9-7/h1-4H,(H2,8,9,10)
| Molecular Formula | C7H6N2O |
| Molecular Weight | 134.1353 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Isolation and characterization of Pseudomonas sp. CBW capable of degrading carbendazim. | 2010-11 |
|
| Biodegradation of carbendazim by a novel actinobacterium Rhodococcus jialingiae djl-6-2. | 2010-10 |
|
| Computational thermochemistry of six ureas, imidazolidin-2-one, N,N'-trimethyleneurea, benzimidazolinone, parabanic acid, barbital (5,5'-diethylbarbituric acid), and 3,4,4'-trichlorocarbanilide, with an extension to related compounds. | 2010-09-02 |
|
| Inhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules. | 2010-06-24 |
|
| Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation. | 2010-06 |
|
| 1-Isopropenyl-1H-1,3-benzimidazol-2(3H)-one. | 2010-05-22 |
|
| Identification of potent, highly constrained CGRP receptor antagonists. | 2010-04-15 |
|
| 1-{[(Cyclo-hexyl-oxy)carbon-yl]-oxy}ethyl 3-{[2'-(2-ethyl-2H-tetra-zol-5-yl)biphenyl-4-yl]meth-yl}-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxyl-ate. | 2010-03-31 |
|
| Rapid access towards follow-up NOP receptor agonists using a knowledge based approach. | 2009-11-15 |
|
| 1,3-Bis(hydroxy-meth-yl)benzimidazolin-2-one. | 2009-10-17 |
|
| 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors. | 2009-09-24 |
|
| Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents. | 2009-08-15 |
|
| The discovery of highly potent CGRP receptor antagonists. | 2009-01-01 |
|
| Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties. | 2008-03-15 |
|
| Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety. | 2007-09-01 |
|
| Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity. | 2007-08-15 |
|
| DFT studies of the structure and vibrational assignments of 4-hydroxy quinazoline and 2-hydroxy benzimidazole. | 2007-04 |
|
| Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties. | 2007-02-15 |
|
| Benzofused tricycles based on 2-quinoxalinol. | 2007-01-09 |
|
| Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo. | 2006-03-01 |
|
| Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT. | 2005-05-05 |
|
| Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). | 2004-10-11 |
|
| Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives. | 2004-03-08 |
|
| A theoretical study of substituent effects on tautomerism of 2-hydroxybenzimidazoles. | 2003-12 |
|
| Imidazopyridine/Pyrrole and hydroxybenzimidazole/pyrrole pairs for DNA minor groove recognition. | 2003-05-14 |
|
| Preparation of oxime dual NK(1)/NK(2) antagonists with reduced NK(3) affinity. | 2002-09-02 |
|
| New generation dopaminergic agents. Part 8: heterocyclic bioisosteres that exploit the 7-OH-2-(aminomethyl)chroman D(2) template. | 2002-02-11 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:14:37 GMT 2025
by
admin
on
Mon Mar 31 19:14:37 GMT 2025
|
| Record UNII |
CV8118UZEW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
210-412-4
Created by
admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
|
PRIMARY | |||
|
10383
Created by
admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
|
PRIMARY | |||
|
102976-62-5
Created by
admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
|
ALTERNATIVE | |||
|
DTXSID0060642
Created by
admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
|
PRIMARY | |||
|
11985
Created by
admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
|
PRIMARY | |||
|
178108
Created by
admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
|
PRIMARY | |||
|
CV8118UZEW
Created by
admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
|
PRIMARY | |||
|
615-16-7
Created by
admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|